Screener
Nurix Therapeutics, Inc. NRIX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Nurix Therapeutics, Inc.’s 8-K, filed July 9, 2026. Open the filing →
- Filed
- Jul 9, 2026, 4:09 PM EDT
- Accession
- 0001549595-26-000038
FAQ
- What is Nurix Therapeutics, Inc.'s asset turnover?
- Nurix Therapeutics, Inc. (NRIX) reported asset turnover of 0.1× in Q1 2026.
- How has Nurix Therapeutics, Inc.'s asset turnover changed year-over-year?
- Nurix Therapeutics, Inc.'s asset turnover decreased by 59.3% year-over-year, from 0.2× to 0.1×.
- What is the long-term trend for Nurix Therapeutics, Inc.'s asset turnover?
- Over 5 years (2020 to 2025), Nurix Therapeutics, Inc.'s asset turnover has grown at a 8.9% compound annual growth rate (CAGR), from 0.1× to 0.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Nurix Therapeutics, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude